US2013053355A1PendingUtilityA1

Products for anti-inflammation support

47
Individually held — no corporate assignee on recordPriority: Aug 29, 2011Filed: Jun 12, 2012Published: Feb 28, 2013
Est. expiryAug 29, 2031(~5.1 yrs left)· nominal 20-yr term from priority
Inventors:Jonnie R. Williams
A61P 29/00A61K 31/444A61K 47/22A23L 33/10A61K 36/81A23V 2002/00A23L 33/105A23L 29/03A61K 31/593A23P 10/20A61K 31/07A61K 31/4545A23L 33/155
47
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This disclosure provides products, including pharmaceutical compositions and dietary supplements, which are useful for anti-inflammatory support.

Claims

exact text as granted — not AI-modified
1 . A product comprising:
 a compound of Formula I   
       
         
           
           
               
               
           
         
       
       wherein R represents hydrogen or C 1 -C 5  alkyl; R′ represents hydrogen or C 1 -C 7  alkyl; and X represents halogen or C 1 -C 7  alkyl, or a pharmaceutically acceptable salt thereof; and
 a vitamin. 
 
     
     
         2 . The product of  claim 1 , wherein R represents hydrogen or C 1 -C 3  alkyl. 
     
     
         3 . The product of  claim 1 , wherein R′ represents hydrogen or C 1 -C 4  alkyl. 
     
     
         4 . The product of  claim 1 , wherein X represents halogen or C 1 -C 3  alkyl. 
     
     
         5 . The product of  claim 1 , wherein the compound is anatabine. 
     
     
         6 . The product of  claim 5 , wherein the compound is S-(−)-anatabine. 
     
     
         7 . The product of  claim 5 , wherein the compound is R-(+)-anatabine. 
     
     
         8 . The product of  claim 1 , wherein the vitamin is Vitamin A. 
     
     
         9 . The product of  claim 1 , wherein the vitamin is Vitamin D3. 
     
     
         10 . The product of  8 , further comprising Vitamin D3. 
     
     
         11 . The product of  claim 5 , wherein the anatabine is synthetic anatabine. 
     
     
         12 . The product of  claim 5 , wherein the anatabine is provided in the form of an extract from a plant. 
     
     
         13 . The product of  claim 5 , which comprises anatabine in an amount of about 1 mg. 
     
     
         14 . The product of  claim 1 , which comprises Vitamin A in an amount of about 417 IU. 
     
     
         15 . The product of  claim 1 , comprising Vitamin D3 in an amount of about 33 IU. 
     
     
         16 . The product of  claim 1 , further comprising one or more additional ingredients selected from the group consisting of mannitol, natural and artificial mint flavors, sucralose, silicon dioxide, stearic acid, hydroxypropyl methylcellulose, magnesium stearate, titanium dioxide, natural glaze, methyl parabens, propylparabens, triethyl citrate, citric acid, BHT, mono and diglycerides, and polysorbate 80. 
     
     
         17 . The product of  claim 1 , which is a dietary supplement. 
     
     
         18 . The product of  claim 1 , which is a pharmaceutical composition. 
     
     
         19 . A method of providing anti-inflammation support, comprising administering to an individual in need thereof a product comprising:
 a compound of Formula I   
       
         
           
           
               
               
           
         
       
       wherein R represents hydrogen or C 1 -C 5  alkyl; R′ represents hydrogen or C 1 -C 7  alkyl; and X represents halogen or C 1 -C 7  alkyl, or a pharmaceutically acceptable salt thereof; and
 a vitamin. 
 
     
     
         20 . The method of  claim 19 , wherein the individual is human.

Join the waitlist — get patent alerts

Track US2013053355A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.